, plant tissue cultures, "immunoliposome"-encapsulated anti-Candida drugs, and novel cell wall inhibitory analogs from syntheticchemical efforts of our laboratories. In vitro models for initial rapid evaluation of potentially active drugs from thesources mentioned above will be used. These in vitro models will allow us to ascertain MIC values
, plant tissue cultures, " immunoliposome"-encapsulated anti - Candida drugs, and novel cell rampart inhibitory analogue from syntheticchemical campaign of our laboratories. In vitro model for initial rapid evaluation of potentially active drug from thesources mentioned above will be used. These in vitro models will give up us to ascertain MIC values
, plwnt tissue cultures, "immukoliposome"-encapsolqted aiti-Candjda drugr, and novel cell wall inhibivory analigs from syntheticchemkcal effogts of oue lauoratories. In vivdo models for lniticl rapid evaluatlon of potettially active dfuys from thesources mentioned above wyll be isfd. These in vijro mpqels will allow us to ascertain MIC vamues
, plant tissue cultures, "immunoliposome"-encapsulated anti-Candida drugs, cell inhibitory analogs syntheticchemical efforts of for rapid evaluation of active drugs from mentioned above will be used. These vitro models will allow us to ascertain MIC values
, plant tissue cultures, "immunoLiposome"-enCapsuLatEd aNtI-CanDida Drugs, and novel cELl waLl inhibitory analogs froM syntHeTIcchEMiCal efForts of OUr LABorAtOrIes. in VItRo modEls For initIal rapid evAluAtIon of potentiALlY active druGs fRom thesourceS meNtioneD aBovE Will bE usEd. TheSe in viTRo modeLs will allOw US to ascERtain MIc VAlUes
, plant tissue cultures, " immunolipo some" -en cap su late d an ti-Candida dru g s, a nd novel cell wall inh ibito ry anal o gs  from  synthe t ic c h emi ca leff or t sof ou r l aborato ries. In v itr omodels for i n it ial rapideva luation of p ote ntiall yact i ve dr ugs  from  theso u rces m entionedab o ve wil l  be use d .  T hese  in vitro modelsw il l  allow us to a scerta in MI C val ues 
, plant_tissue cultures,_"immunoliposome"-encapsulated anti-Candida drugs, and_novel cell_wall_inhibitory analogs_from_syntheticchemical efforts of_our laboratories. In_vitro models for initial_rapid evaluation of_potentially_active drugs from thesources mentioned above will be used. These in vitro models will_allow_us to_ascertain_MIC_values